Creation Technologies Launches FDA UDI Compliance Program in Global Manufacturing and Design Operations

Share Article

Electronic product design and contract manufacturing leader demonstrates commitment to medical OEMs in all ten of its manufacturing locations

All Medical Devices Require UDI Labelling to Meet FDA Requirements

All Medical Devices Require UDI Labelling to Meet FDA Requirements

Creation Technologies is committed to exceeding all patient safety requirements on behalf of our innovative OEM medical customers. Creation believes integrating critical UDI traceability information into our Vision system adds exceptional value.

Creation Technologies, award-winning EMS provider with electronics Design, Rapid Prototyping and Manufacturing locations around the globe, today announced its milestone achievement of the USA Food and Drug Administration (FDA) Unique Device Identifier (UDI) Compliance for Class I, Class II and Class III medical device labeling across its global operations.

As an established contract design and manufacturing partner for leading medical device OEMs, Creation’s manufacturing facilities are ISO 13485-certified and FDA-registered. With the recent FDA-mandated UDI compliance date of September 24, 2016 for Class II medical devices, Creation has achieved compliance with the regulation. Moreover, the company has announced implementation of a proprietary new tool and automated process within its Vision manufacturing execution system and customer portal that enables its customers to obtain real-time data and device tracking information in support of their UDI compliance.

For more information on the FDA's Unique Device Identification

“Creation Technologies is committed to exceeding all patient safety requirements on behalf of our innovative OEM medical customers. Achieving FDA UDI System compliance for all medical device classes in advance of the 2020 deadline demonstrates this commitment. Creation believes integrating critical UDI traceability information into our Vision system adds exceptional value,” said Tim Holzschuh, Director of Regulatory & Quality – Creation Design Services. “The medical device industry anticipates that the return on investment for the UDI System will include less reporting of adverse events, faster regulatory submission turn-around times, and more efficient post-market vigilance.”

Additional information about the FDA’s Unique Device Identification requirements can be found in UDI Basics and other resources on the FDA’s website.

About Creation Technologies

With FDA-registered and ISO 13485-certified manufacturing facilities and design centers across Canada, USA, Mexico and China, Creation Technologies provides real-time visibility and traceability to its medical customers in markets from cardiovascular to urology imaging to radiation oncology.

Medical device and biotechnology companies working with Creation Technologies have scalable options for risk mitigation and rapid growth through the company’s turnkey solutions that include connected device design and development, rapid prototyping, manufacturing, fulfillment and logistics for complex systems, and VAVE and sustaining engineering.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Janelle Urchenko

Jennifer Marsh
@creationtech
Follow >
Visit website